Virpax Pharmaceuticals Engages New England Investors to Direct Licensing Strategy for Envelta™ in China
Medical Marijuana Program Connection
JANUARY 31, 2023
–(BUSINESS WIRE)–Virpax® Pharmaceuticals, Inc. Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing non-addictive products for pain. BERWYN, Pa.–(BUSINESS Read More
Let's personalize your content